{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:27:29Z","timestamp":1791844049040,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.1038\/nm1468","type":"journal-article","created":{"date-parts":[[2006,9,3]],"date-time":"2006-09-03T13:29:37Z","timestamp":1157290177000},"page":"1056-1064","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":425,"title":["Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Adriano G","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A","family":"Sawatzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara A","family":"Sheldrake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola A","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Caldicott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Martinez-Losa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor R","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodger","family":"Duffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Crescenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morag C","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh J","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Savill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Dransfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Haslett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,3]]},"reference":[{"key":"BFnm1468_CR1","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01320","volume":"420","author":"C Nathan","year":"2002","unstructured":"Nathan, C. Points of control in inflammation. Nature 420, 846\u2013852 (2002).","journal-title":"Nature"},{"key":"BFnm1468_CR2","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1172\/JCI113970","volume":"83","author":"JS Savill","year":"1989","unstructured":"Savill, J.S. et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83, 865\u2013875 (1989).","journal-title":"J. Clin. Invest."},{"key":"BFnm1468_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/343170a0","volume":"343","author":"J Savill","year":"1990","unstructured":"Savill, J., Dransfield, I., Hogg, N. & Haslett, C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343, 170\u2013173 (1990).","journal-title":"Nature"},{"key":"BFnm1468_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd1383","volume":"3","author":"DW Gilroy","year":"2004","unstructured":"Gilroy, D.W., Lawrence, T., Perretti, M. & Rossi, A.G. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401\u2013416 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm1468_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152306775537319","volume":"5","author":"NA Riley","year":"2006","unstructured":"Riley, N.A. et al. Granulocyte apoptosis and macrophage clearance of apoptotic cells as targets for pharmacological intervention in inflammatory diseases. Anti-Inflamm. Anti-Allergy Agents Medicinal Chem. 5, 3\u201312 (2006).","journal-title":"Anti-Inflamm. Anti-Allergy Agents Medicinal Chem."},{"key":"BFnm1468_CR6","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.4049\/jimmunol.150.11.5124","volume":"150","author":"MK Whyte","year":"1993","unstructured":"Whyte, M.K., Meagher, L.C., MacDermot, J. & Haslett, C. Impairment of function in aging neutrophils is associated with apoptosis. J. Immunol. 150, 5124\u20135134 (1993).","journal-title":"J. Immunol."},{"key":"BFnm1468_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nm1248","volume":"11","author":"H Jonsson","year":"2005","unstructured":"Jonsson, H., Allen, P. & Peng, S.L. Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat. Med. 11, 666\u2013671 (2005).","journal-title":"Nat. Med."},{"key":"BFnm1468_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","volume":"36","author":"K Vermeulen","year":"2003","unstructured":"Vermeulen, K., Van Bockstaele, D.R. & Berneman, Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36, 131\u2013149 (2003).","journal-title":"Cell Prolif."},{"key":"BFnm1468_CR9","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1038\/sj.onc.1206954","volume":"22","author":"AM Senderowicz","year":"2003","unstructured":"Senderowicz, A.M. Small-molecule cyclin-dependent kinase modulators. Oncogene 22, 6609\u20136620 (2003).","journal-title":"Oncogene"},{"key":"BFnm1468_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/0929867033368277","volume":"10","author":"EA Monaco III.","year":"2003","unstructured":"Monaco, E.A., III. & Vallano, M.L. Cyclin-dependent kinase inhibitors: cancer killers to neuronal guardians. Curr. Med. Chem. 10, 367\u2013379 (2003).","journal-title":"Curr. Med. Chem."},{"key":"BFnm1468_CR11","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1158\/0008-5472.CAN-05-0233","volume":"65","author":"DE MacCallum","year":"2005","unstructured":"MacCallum, D.E. et al. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1. Cancer Res. 65, 5399\u20135407 (2005).","journal-title":"Cancer Res."},{"key":"BFnm1468_CR12","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1182\/blood-2005-01-0320","volume":"106","author":"N Raje","year":"2005","unstructured":"Raje, N. et al. Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma. Blood 106, 1042\u20131047 (2005).","journal-title":"Blood"},{"key":"BFnm1468_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.biocel.2004.04.007","volume":"37","author":"J Michels","year":"2005","unstructured":"Michels, J., Johnson, P.W. & Packham, G. Mcl-1. Int. J. Biochem. Cell Biol. 37, 267\u2013271 (2005).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFnm1468_CR14","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1182\/blood.V92.7.2495","volume":"92","author":"DA Moulding","year":"1998","unstructured":"Moulding, D.A., Quayle, J.A., Hart, C.A. & Edwards, S.W. Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood 92, 2495\u20132502 (1998).","journal-title":"Blood"},{"key":"BFnm1468_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1432-1033.1997.0518a.x","volume":"243","author":"WF De Azevedo","year":"1997","unstructured":"De Azevedo, W.F. et al. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur. J. Biochem. 243, 518\u2013526 (1997).","journal-title":"Eur. J. Biochem."},{"key":"BFnm1468_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1432-1033.1997.t01-2-00527.x","volume":"243","author":"L Meijer","year":"1997","unstructured":"Meijer, L. et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527\u2013536 (1997).","journal-title":"Eur. J. Biochem."},{"key":"BFnm1468_CR17","doi-asserted-by":"publisher","first-page":"31208","DOI":"10.1074\/jbc.M500806200","volume":"280","author":"S Bach","year":"2005","unstructured":"Bach, S. et al. Roscovitine targets, protein kinases and pyridoxal kinase. J. Biol. Chem. 280, 31208\u201331219 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnm1468_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1126\/science.281.5376.533","volume":"281","author":"NS Gray","year":"1998","unstructured":"Gray, N.S. et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281, 533\u2013538 (1998).","journal-title":"Science"},{"key":"BFnm1468_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1074-5521(99)80048-9","volume":"6","author":"YT Chang","year":"1999","unstructured":"Chang, Y.T. et al. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chem. Biol. 6, 361\u2013375 (1999).","journal-title":"Chem. Biol."},{"key":"BFnm1468_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1074-5521(00)00063-6","volume":"7","author":"L Meijer","year":"2000","unstructured":"Meijer, L. et al. Inhibition of cyclin-dependent kinases, GSK-3\u03b2 and CK1 by hymenialdisine, a marine sponge constituent. Chem. Biol. 7, 51\u201363 (2000).","journal-title":"Chem. Biol."},{"key":"BFnm1468_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/1521-4141(200002)30:2<709::AID-IMMU709>3.0.CO;2-9","volume":"30","author":"O Williams","year":"2000","unstructured":"Williams, O., Gil-Gomez, G., Norton, T., Kioussis, D. & Brady, H.J. Activation of Cdk2 is a requirement for antigen-mediated thymic negative selection. Eur. J. Immunol. 30, 709\u2013713 (2000).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1468_CR22","doi-asserted-by":"publisher","first-page":"45041","DOI":"10.1074\/jbc.M105197200","volume":"276","author":"MC Martin","year":"2001","unstructured":"Martin, M.C., Dransfield, I., Haslett, C. & Rossi, A.G. Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J. Biol. Chem. 276, 45041\u201345050 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnm1468_CR23","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1074\/jbc.274.7.4309","volume":"274","author":"C Ward","year":"1999","unstructured":"Ward, C. et al. NF-\u03baB activation is a critical regulator of human granulocyte apoptosis in vitro. J. Biol. Chem. 274, 4309\u20134318 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnm1468_CR24","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/eji.200425561","volume":"35","author":"C Ward","year":"2005","unstructured":"Ward, C. et al. Interleukin-10 inhibits lipopolysaccharide-induced survival and extracellular signal-regulated kinase activation in human neutrophils. Eur. J. Immunol. 35, 2728\u20132737 (2005).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1468_CR25","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.4049\/jimmunol.168.9.4701","volume":"168","author":"I Sabroe","year":"2002","unstructured":"Sabroe, I., Jones, E.C., Usher, L.R., Whyte, M.K. & Dower, S.K. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 168, 4701\u20134710 (2002).","journal-title":"J. Immunol."},{"key":"BFnm1468_CR26","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.4049\/jimmunol.170.10.5268","volume":"170","author":"I Sabroe","year":"2003","unstructured":"Sabroe, I. et al. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J. Immunol. 170, 5268\u20135275 (2003).","journal-title":"J. Immunol."},{"key":"BFnm1468_CR27","doi-asserted-by":"publisher","first-page":"53932","DOI":"10.1074\/jbc.M408467200","volume":"279","author":"JL Rosales","year":"2004","unstructured":"Rosales, J.L., Ernst, J.D., Hallows, J. & Lee, K.Y. GTP-dependent secretion from neutrophils is regulated by Cdk5. J. Biol. Chem. 279, 53932\u201353936 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1468_CR28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/9550","volume":"5","author":"DW Gilroy","year":"1999","unstructured":"Gilroy, D.W. et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5, 698\u2013701 (1999).","journal-title":"Nat. Med."},{"key":"BFnm1468_CR29","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1096\/fj.02-1162fje","volume":"17","author":"DW Gilroy","year":"2003","unstructured":"Gilroy, D.W. et al. Inducible cyclooxygenase-derived 15-deoxy(\u0394)12\u201314PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. FASEB J. 17, 2269\u20132271 (2003).","journal-title":"FASEB J."},{"key":"BFnm1468_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2353\/ajpath.2006.050058","volume":"168","author":"DA Sawatzky","year":"2006","unstructured":"Sawatzky, D.A., Willoughby, D.A., Colville-Nash, P.R. & Rossi, A.G. The involvement of the apoptosis-modulating proteins ERK 1\/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo. Am. J. Pathol. 168, 33\u201341 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnm1468_CR31","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1164\/rccm.200504-538OC","volume":"173","author":"JF Cailhier","year":"2006","unstructured":"Cailhier, J.F. et al. Resident pleural macrophages are key orchestrators of neutrophil recruitment in pleural inflammation. Am. J. Respir. Crit. Care Med. 173, 540\u2013547 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnm1468_CR32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1189\/jlb.1003474","volume":"75","author":"P Klausen","year":"2004","unstructured":"Klausen, P., Bjerregaard, M.D., Borregaard, N. & Cowland, J.B. End-stage differentiation of neutrophil granulocytes in vivo is accompanied by up-regulation of p27kip1 and down-regulation of CDK2, CDK4, and CDK6. J. Leukoc. Biol. 75, 569\u2013578 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm1468_CR33","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/jcb.10526","volume":"89","author":"Y Tsukahara","year":"2003","unstructured":"Tsukahara, Y. et al. Gene expression in human neutrophils during activation and priming by bacterial lipopolysaccharide. J. Cell. Biochem. 89, 848\u2013861 (2003).","journal-title":"J. Cell. Biochem."},{"key":"BFnm1468_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1189\/jlb.0903412","volume":"75","author":"X Zhang","year":"2004","unstructured":"Zhang, X. et al. Gene expression in mature neutrophils: early responses to inflammatory stimuli. J. Leukoc. Biol. 75, 358\u2013372 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm1468_CR35","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1182\/blood.V97.8.2457","volume":"97","author":"YV Subrahmanyam","year":"2001","unstructured":"Subrahmanyam, Y.V. et al. RNA expression patterns change dramatically in human neutrophils exposed to bacteria. Blood 97, 2457\u20132468 (2001).","journal-title":"Blood"},{"key":"BFnm1468_CR36","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1189\/jlb.0605289","volume":"78","author":"SD Kobayashi","year":"2005","unstructured":"Kobayashi, S.D., Voyich, J.M., Whitney, A.R. & DeLeo, F.R. Spontaneous neutrophil apoptosis and regulation of cell survival by granulocyte macrophage-colony stimulating factor. J. Leukoc. Biol. 78, 1408\u20131418 (2005).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm1468_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pupt.2005.01.007","volume":"18","author":"E Azambuja","year":"2005","unstructured":"Azambuja, E., Fleck, J.F., Batista, R.G. & Menna Barreto, S.S. Bleomycin lung toxicity: who are the patients with increased risk? Pulm. Pharmacol. Ther. 18, 363\u2013366 (2005).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"BFnm1468_CR38","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nm0502-480","volume":"8","author":"T Nagase","year":"2002","unstructured":"Nagase, T. et al. A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis. Nat. Med. 8, 480\u2013484 (2002).","journal-title":"Nat. Med."},{"key":"BFnm1468_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1126\/science.1069659","volume":"296","author":"P Teder","year":"2002","unstructured":"Teder, P. et al. Resolution of lung inflammation by CD44. Science 296, 155\u2013158 (2002).","journal-title":"Science"},{"key":"BFnm1468_CR40","doi-asserted-by":"publisher","first-page":"L730","DOI":"10.1152\/ajplung.00120.2004","volume":"287","author":"ME De Paepe","year":"2004","unstructured":"De Paepe, M.E., Mao, Q., Embree-Ku, M., Rubin, L.P. & Luks, F.I. Fas\/FasL-mediated apoptosis in perinatal murine lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L730\u2013L742 (2004).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFnm1468_CR41","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/89759","volume":"2","author":"BD Levy","year":"2001","unstructured":"Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K. & Serhan, C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612\u2013619 (2001).","journal-title":"Nat. Immunol."},{"key":"BFnm1468_CR42","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"CN Serhan","year":"2002","unstructured":"Serhan, C.N. et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025\u20131037 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnm1468_CR43","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"CN Serhan","year":"2005","unstructured":"Serhan, C.N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191\u20131197 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnm1468_CR44","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","volume":"176","author":"CN Serhan","year":"2006","unstructured":"Serhan, C.N. et al. Anti-inflammatory actions of neuroprotectin D1\/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176, 1848\u20131859 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1468_CR45","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1189\/jlb.0704386","volume":"77","author":"V Pinho","year":"2005","unstructured":"Pinho, V. et al. Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J. Leukoc. Biol. 77, 800\u2013810 (2005).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm1468_CR46","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ijc.10738","volume":"102","author":"SJ McClue","year":"2002","unstructured":"McClue, S.J. et al. In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). Int. J. Cancer 102, 463\u2013468 (2002).","journal-title":"Int. J. Cancer"},{"key":"BFnm1468_CR47","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L.M. & Werb, Z. Inflammation and cancer. Nature 420, 860\u2013867 (2002).","journal-title":"Nature"},{"key":"BFnm1468_CR48","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin, M. & Greten, F.R. NF-\u03baB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749\u2013759 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1468_CR49","first-page":"101","volume":"119","author":"C Haslett","year":"1985","unstructured":"Haslett, C., Guthrie, L.A., Kopaniak, M.M., Johnston, R.B., Jr. & Henson, P.M. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 119, 101\u2013110 (1985).","journal-title":"Am. J. Pathol."},{"key":"BFnm1468_CR50","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1093\/emboj\/17.24.7209","volume":"17","author":"G Gil-Gomez","year":"1998","unstructured":"Gil-Gomez, G., Berns, A. & Brady, H.J. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J. 17, 7209\u20137218 (1998).","journal-title":"EMBO J."}],"updated-by":[{"DOI":"10.1038\/nm1206-1434","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1468","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:27:41Z","timestamp":1684434461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9,1]]}},"alternative-id":["BFnm1468"],"URL":"https:\/\/doi.org\/10.1038\/nm1468","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1046391.496348","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,1]]},"assertion":[{"value":"26 October 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2006","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, the dose stated for zVAD-fmk administration was incorrect. The methods reported on page 1062 should read \"Twenty-four hours after intrapleural injection of carrageenan, mice were injected i.p. with 10 mg per kg of R-roscovitine and\/or 5 mg per kg of zVAD-fmk (z-Val-Ala-DL-Asp-fluoromethylketone; Bachem)\". Similarly, the legend to figure 4, line 3, should read \u201cC57\/bl6 mice were treated with 10 mg per kg of R-roscovitine (i.p.) and\/or 5 mg per kg of zVAD-fmk (i.p. at 4-h intervals)\u201d. We also made an error reporting the time of administration of K\/Bxn serum in the legend to figure 5, line 14. This should read \u201cMice (n =10 in each group) were injected twice (days 0 and 2) with K\/BxN serum derived from arthritic (day 60) K\/BxN transgenic mice.\u201d The error has been corrected in the HTML and PDF versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}